Efficiency and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibody on hypercholesterolemia: a meta-analysis of 20 randomized controlled trials

Journal of the American Heart Association

Volumn 4, Issue 6, 2015, Pages e001937-

  Li, Chuanwei ^a   Lin, Ling ^a   Zhang, Wen ^a   Zhou, Liang ^a   Wang, Hongyong ^a   Luo, Xiaoli ^a   Luo, Hao ^a   Cai, Yue ^a   Zeng, Chunyu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

lipids; lipoproteins; meta analysis; proprotein convertase subtilisin kexin9 inhibitor

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; PCSK9 PROTEIN, HUMAN; PROPROTEIN CONVERTASE 9; SERINE PROTEINASE;

ANTAGONISTS AND INHIBITORS; BLOOD; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOLOGY; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; PROPROTEIN CONVERTASE 9; PROPROTEIN CONVERTASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME;

EID: 85018197350     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.001937     Document Type: Article

References (0)